Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 5, 1996, Pages 267-272

  Wallin, Anders ^a   Blennow, Kaj ^a   Rosengren, Lars E ^b  

^a Department ofPsychiatry and Neurochemistry ^*  (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Alzheirher s disease; Cerebrospinal fluid; Frontal lobe dementia; Glial fibrillary acidic protein; Vascular dementia

Indexed keywords

ALBUMIN; GLIAL FIBRILLARY ACIDIC PROTEIN; STRUCTURAL PROTEIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOSIS; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; FEMALE; HUMAN; INTERMEDIATE FILAMENT; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SENILE DEMENTIA;

ADULT; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; FRONTAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; SERUM ALBUMIN;

EID: 0029782171     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106891     Document Type: Article

References (57)

1. Bignami A, Dahl D: The astroglial response to stabbing, Immunofluorescence studies with antibodies to astrocyte-spccific protein (GFA) in mammalian and submammalian vertebrates, Neuropathol AppI Neurobiol 1976;2:99-110.
2. Rueger DC, Huston JS, Dahl D, Bignami A: Formation of 100 Ä filaments from purified glial fibrillarv acidic protein in vitro, J Mol Biol 1979:135:53-68.
3. Duchen LW: General pathology of neurones and neuroglia: in Adams JH, Corscllis JAN, Duchen LW (eds): Greenfield's Neuropathology, London, Edward Arnold, 1984. pp 1-52.
4. Norenberg MD: Astrocytic response to CNS injury, J Neuropathol Exp Neurol 1994;53: 213-220.
5. Mancardi GL, Liwnicz BH, Mandybur TI: Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type, Acta Ncu-ropathol 1983:61:76-80.
6. Beach TG, Walker R, McGccr EG: Patterns of gliosis in Alzheimer's disease and aging cerebrum, Glia 1989;2:420-436.
7. Mandybur TI, Chuirazzi CC: Astrocytes and the plaques of Alzheimer’s disease, Neurology 1990;40:635-639.
8. Brierly JB, Graham DI: Hypoxia and vascular disorder of the central nervous system; in Adams JH, Corsellis JAN, Duchen LW (eds): Greenfield's Neuropathology, London, Edward Arnold, 1984. pp 125-207.
9. Englund E, Brun A: Frontal lobe degeneration of non-Alzheimer type, IV, White matter changes, Arch Gerontol Geriatr 1987:6:235- 243.
10. Delacourtc A: General and dramatic glial reaction in Alzheimer brains, Neurology 1990;40: 33-37.
11. Jörgensen OS, Brooksbank BWL, Baltz R: Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease, J Neurol Sei 1990;98:63-79.
12. Noppe M, Crols R, Andrics D, Lowcnlhal A: Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology, Clin Chim Acta 1986:155:143-150.
13. Crols R, Sacrcns J, Noppe M, Lowcnlhal A: Increased GFAP levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome, J Neurol 19S6:233:157-160.
14. Roscngren LE, Ahlscn G, Belfrage M, Gillberg C, Haglid KG, Hambergcr A: A sensitive ELISA for glial fibrillary acidic protein: Application in CSF of children, J Neurosci Methods 1992;44:113-119.
15. Roscngren LE, Wikkelso C, Hagberg L: A sensitive ELISA for glial fibrillary acidic protein: Application in the CSF of adults, J Neurosci Methods 1994;51:197-204.
16. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders, ed 3. revised, Washington, American Psychiatric Association, 1987.
17. McKliann G, Drachman D, Folstcin M, Katz-man R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease, Neurology 1984:34:939-944.
18. Wallin A, Blennow K, Scheltcns Ph: Research criteria for clinical diagnosis of 'pure' Alzheimer's disease, Drugs Today 1994:30:265-273.
19. Blennow K, Wallin A: Clinical heterogeneity of 'probable Alzheimer's disease', J Geriatr Psychiatry Neurol 1992:5:106-113.
20. Wallin A, Blennow K; The clinical diagnosis of vascular dementia, Dementia 1994:5:181-184.
21. Wallin A, Blennow K, Goltfries CG: Subcorti-cal symptoms predominate in vascular dementia, Int J Geriatr Psychiatry 1991;6:137-146.
22. Román GC, Talemichi TK, Erkinjuntti T, Cummings JL, Masdcu JC, Garcia JH, Ama-ducci L, Orgogozo JM, Brun A, Hofman V Moody DM, O'Brien MD, Yamaguchi T, Graf-man J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorclick PB, Bick KL, Pajcau AK, Bell MA, DcCavli C, Culebras A, Korczvn AD, Bogousslavsky J, Hartmann A, Schcinbcrg P: Vascular dementia: Diagnostic criteria for research studies, Report of the NINDS-ARIEN International Workshop, Neurology 1993:43:250-260.
23. Wallin A, Blennow K: Clinical subgroups of the Alzheimer syndrome, Acta Neurol Scand, in press
24. Gustafson L: Frontal lobe degeneration of non-Alzheimer type, II, Clinical picture and differential diagnosis, Arch Gerontol Geriatr 1987:6: 209-223.
25. The Lund and Manchester Groups: Clinical and neuropathological criteria for Irontotem-poral dementia, J Neurol Ncurosurg Psychiatry 1994;57:416-418.
26. Folstcin M, Folstcin S, McHugh P: 'Mini-Mcn-tal-Stalc’: A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 1975:12:189-198.
27. Tibbling G, Link II, Óhman S: Principles of albumin and IgG analyses in neurological disorders, 1. Establishment of reference values, Scand J Clin Lab Invest 1977:37:385-390.
28. Tomlinson BE, Corscllis JAN: Ageing and the dementias: in Adams JH, Corsellis JAN, Duchen LW (eds): Greenfield's Neuropathology, London Edward Arnold, 1984. pp 951-1051.
29. Babikian V, Roppcr AH: Binswangcr'sdisease: A review, Stroke 1987;18:2-12.
30. Aurell A, Rosengrcn LE, Olsson JE, Zbomi-kova V, Haglid KG: Determination of S-100 and GFAP protein concentration in cerebrospinal fluid after brain infarction, Stroke 1991: 22:1254-1258.
31. Roscngren LE, Kjcllstrand P, Haglid KG: Long term neurotoxicity of styrene, A quantitative study of glial fibrillary acidic protein (GFA) and S-100. Br J Intern Med 1989;46:316-320.
32. Mancardi GL, Romagnoli P, Tassinari T, Gan-dolfo C, Primavera A, Loeb C: Lacunae and cribriform cavities of the brain, Correlations with pseudobulbar palsy and parkinsonism, Eur Neurol 198S;28:11-17.
33. Ma K-C, Olsson V: Structural and vascular permeability abnormalities associated with la-cunes of the human brain, Acta Neurol Scand 1993;88:100-107.
34. Caims NJ, Chadwick A, Luthert PJ, Lantos PL: Astrocytosis, PA4-protein deposition and paired helical filament formation in Alzheimer's disease, J Neurol Sci 1992; 112:98.
35. Wisniewski HM, Wcgiel J: Spatial relationship between astrocytes and classical plaque components, Ncurobiol Aging 1991;12:593-600.
36. Yamaguchi H, Morimatsu M, Hirari S, Taka-hashi K: Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages, Acta Neuro-pathol 1987;72:214-217.
37. Fredrickson RCA: Astroglia in Alzheimer's disease, Neurobiol Aging 1992;13:239-253.
38. Nielo-Sampcrdo M, Mora F: Active microglia, sick astroglia and Alzheimer type dementias, Ncurorcport 1994;5:375-380.
39. Simon R, Card JP, Nelson RB, Davis LG: Expression of P-amyloid precursor protein in reactive astrocytes following neuronal damage, Neuron 1989;3:275-285.
40. Vijayan VK, Geddcs JW, Anderson KJ, Chan-Chui H, Ellis WG, Cotman CW: Astrocyte hypertrophy in the Alzheimer disease formation, Exp Neurol 1991; 112:72-78.
41. Blcnnow K, Wallin A, Uhlcmann C, Gottfries CG: White matter lesions on CT in Alzheimer's disease - relation to clinical symptomatology and vascular factors, Acta Neurol Scand 1991; 83:187-193.
42. Blcnnow K, Davidsson P, Wallin A, Fredman P, Gottfries CG, Karlsson I, Minsson JE, Svcn-ncrholm L: Gangliosides in cerebrospinal fluid in subgroups of Alzheimer's disease, Arch Neurol 1991;48:1032-1035.
43. Svcnnerholm L, Gottfries CG: Membrane lipids selectively diminished in Alzheimer brains suggest synapse loss as primary event in early onset form (Type I) and dcmyclination in late onset form (Type II), J Neurochem 1994;62: 1039-1047.
44. Harpin ML, Delaere P, Javoy-Agid F, Bock E, Jacquc C, Delpech B, Villarroya H, Duyckacrts C, Hauw JJ, Baumann N: Glial fibrillary acidic protein and pA4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: Relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles, J Ncurosci Res 1990;27:587-594.
45. Hansen LA, Armstrong DM, Terry RD: An immunohistochcmical quantitation of fibrous astrocytes in aging human cerebral cortex, Neurobiol Aging 1987;8:1-6.
46. Goss JR, Finch CE, Morgan DG: Age-related changes in glial fibrillary acidic protein mRNA in the mouse brain, Neurobiol Aging 1987;8:1-6.
47. van Swictcn JC, van den Hout JHW, van Ketel BA, Hijdra A, Wokkc JHJ, van Gijn J: Periventricular lesions in the white matter on magnetic resonance imaging in the elderly, Brain 1991; 114:761-774.
48. Englund E, Brun A, Ailing C: White matter changes in dementia of Alzheimer's type, Brain 1988;111:1425-1439.
49. Ferrer I, Bella R, Serrano MT, Marti E, Guio-net N: Arteriosclerotic leukoenccphalopalhy in the elderly and its relation to white matter lesions in Binswangcr's disease, multi-infarct encephalopathy and Alzheimer’s disease, JNeurol Sci 1990;98:37-50.
50. Nakamura Y, Takcda M, Angclides KJ, Tada K, Hariguchi S, Nishimura T: Assembly, disassembly, and exchange of glial fibrillary acidic protein, Glia 1991;4:101-110.
51. DcArmond SJ, Fajardo M, Naughton SA: Degradation of glial fibrillary' acidic protein by a calcium dependent proteinase: An elcctroblot study, Brain Res 1983;262:275-282.
52. Brun A, Englund E: A white matter disorder in dementia of the Alzheimer type: A pathoana-tomical study, Ann Neurol 1986;19:253-262.
53. Wallin A, Blcnnow K, Fredman P, Gottfries CG, Karlsson 1. Svcnnerholm L: Blood brain barrier function in vascular dementia, Acta Neurol Scand 1990;81:318-322.
54. Brun A, Frcdriksson K, Gustafson L: Pure sub-cortical arteriosclerotic encephalopathy (Bins-wanger's disease): A clinicopathological study, Part 2: Pathologic features, Cerebrovasc Dis 1992;2:87-92.
55. Blennow K, Wallin A, Gottfries CG, Karlsson I, Svenncrholm L: Blood-brain barrier disturbance in Alzheimer's disease is related to vascular factors, Acta Neurol Scand I990;81:323-326.
56. Wallin A, Blennow K: The pathogenetic basis of vascular dementia, Alzheimer Dis Assoc Disord 1991;5:91-102.
57. Nordborg C, Sokrab TE, Johansson BB: The relationship between plasma protein extravasation and remote tissue changes after experimental brain infarction, Acta Neuropathol (Berl) 1991;82:118-126.